Second Clinical Trial Getting Underway for PathMaker’s Non-Invasive ALS Treatment PlatformBOSTON, Feb. 04, 2025 (GLOBE NEWSWIRE) -- (“PathMaker”), a clinical-stage neuromodulation company developing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback